(S1 (S (NP (VBN Increased) (NN Foxp3) (NN Protein) (NN Expression)) (VP (VBZ Is) (VP (VBN Associated) (PP (IN with) (NP (JJ Low) (NN HTLV-I) (JJ Proviral) (NN Load)))))))
(S1 (S (SBAR (IN Since) (S (NP (NN Foxp3)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB almost) (RB exclusively)) (PP (IN within) (NP (NN CD4+CD25+) (NN T) (NNS cells)) (, ,) (NP (NP (DT a) (JJ major) (JJ viral) (NN reservoir)) (PP (IN for) (NP (NN HTLV-I) (-LRB- -LSB-) (CD 33) (-RRB- -RSB-))))))))) (, ,) (NP (PRP it)) (VP (VBD was) (ADJP (JJ important) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NN Foxp3)) (CC and) (NP (NN HTLV-I) (NN replication)))) (PP (IN in) (NP (JJ infected) (NNS patients)))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBN quantitated) (NP (NP (DT the) (NN Foxp3) (NN protein) (NN expression)) (PP (IN in) (NP (JJ CD4+CD25+) (NN T) (NNS cells)))) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (CC and) (NP (NP (DT the) (NN HTLV-I) (JJ proviral) (NN load)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ surrogate) (NN marker)) (PP (IN of) (NP (JJ viral) (NN replication)))) (-RRB- -RRB-))))) (PP (IN by) (NP (NP (JJ real-time) (NN PCR)) (PP (IN from) (NP (NP (NP (CD eight) (NNS patients)) (PP (IN with) (NP (NN HAM/TSP)))) (CC and) (NP (NP (CD eight) (JJ asymptomatic) (NNS carriers)) (PRN (-LRB- -LRB-) (NP (NNS ACs)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NNS data)) (PP (IN from) (NP (DT this) (NN analysis)))) (VP (VBZ is) (VP (VBN summarized) (PP (IN in) (NP (NN Table) (CD 1)))))) (. .)))
(S1 (S (SBAR (IN As) (S (VP (VBN expected)))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NN HAM/TSP)))) (VP (VBD exhibited) (NP (NP (ADJP (RB significantly) (JJR higher)) (JJ proviral) (NNS loads)) (PRN (-LRB- -LRB-) (VP (VBN indicated) (PP (IN as) (NP (NN HTLV-I) (JJ proviral) (NN DNA) (NN copies/100) (NNS cells)))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (QP (CD 34.68) (CC +/-) (CD 23.19)) (-RRB- -RRB-)) (PP (VBN compared) (PP (TO to) (NP (NP (NP (NN ACs)) (PRN (-LRB- -LRB-) (QP (CD 4.75) (CC +/-) (CD 5.47)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN p) (JJ =) (NN 0.0008)) (-RRB- -RRB-)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (JJ Foxp3+) (NNS cells)) (PP (IN within) (NP (DT the) (NN CD4+CD25+) (NN T) (NN cell) (NN population)))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR greater)) (PP (IN in) (NP (NP (NNS ACs)) (PRN (-LRB- -LRB-) (QP (CD 43.23) (CC +/-) (CD 12.95)) (-RRB- -RRB-)))) (PP (IN than) (PP (IN in) (NP (NP (NP (NN HAM/TSP) (NNS patients)) (PRN (-LRB- -LRB-) (QP (CD 18.59) (CC +/-) (CD 5.77)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN p) (JJ =) (CD 0.0033)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN Foxp3) (NN protein) (NN expression)))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (VBN reduced) (NN HTLV-I) (NN replication))) (ADVP (FW in) (FW vivo)))))))) (. .)))
(S1 (S (S (NP (PRP They)) (ADVP (RB also)) (VP (VBP support) (NP (NP (PRP$ our) (JJ recent) (NNS reports)) (SBAR (IN that) (S (NP (NP (JJ high) (JJ proviral) (NNS loads)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB correlate) (PP (IN with) (NP (NP (JJ high) (NN Tax) (NN mRNA)) (PP (IN in) (NP (JJ HTLV-I-infected) (NNS patients))))))))))))) (, ,)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (VBN reduced) (NN Foxp3) (NN expression)) (PRN (-LRB- -LSB-) (NP (NN 8,34)) (-RRB- -RSB-))))))))))) (. .)))
